EcoR1 Capital as of March 31, 2018
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 31 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Assembly Biosciences | 14.5 | $145M | 2.9M | 49.14 | |
Ascendis Pharma A S (ASND) | 12.0 | $119M | 1.8M | 65.40 | |
Fibrogen (FGEN) | 9.3 | $93M | 2.0M | 46.20 | |
Ironwood Pharmaceuticals (IRWD) | 9.1 | $91M | 5.9M | 15.43 | |
Kura Oncology (KURA) | 7.1 | $71M | 3.8M | 18.75 | |
Wave Life Sciences (WVE) | 5.9 | $59M | 1.5M | 40.10 | |
Array BioPharma | 5.0 | $50M | 3.0M | 16.32 | |
Dicerna Pharmaceuticals | 4.6 | $46M | 4.8M | 9.56 | |
Macrogenics (MGNX) | 3.7 | $37M | 1.5M | 25.16 | |
Arcus Biosciences Incorporated (RCUS) | 3.5 | $35M | 2.2M | 15.44 | |
Celgene Corp option | 3.4 | $34M | 385k | 89.21 | |
Apellis Pharmaceuticals (APLS) | 2.3 | $23M | 1.1M | 22.11 | |
Five Prime Therapeutics | 2.1 | $21M | 1.2M | 17.18 | |
Urogen Pharma (URGN) | 2.0 | $20M | 402k | 49.69 | |
Fibrogen | 1.5 | $15M | 325k | 46.20 | |
Immune Design | 1.4 | $14M | 4.4M | 3.25 | |
Agios Pharmaceuticals (AGIO) | 1.4 | $14M | 173k | 81.78 | |
Achillion Pharmaceuticals | 1.4 | $14M | 3.7M | 3.70 | |
Akebia Therapeutics (AKBA) | 1.4 | $14M | 1.4M | 9.53 | |
Dova Pharmaceuticals | 1.2 | $12M | 430k | 27.12 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 1.1 | $11M | 3.9M | 2.70 | |
Dbv Technologies S A | 1.0 | $10M | 450k | 23.07 | |
Ironwood Pharmaceuticals Inc cl a | 1.0 | $10M | 668k | 15.43 | |
Protagonist Therapeutics (PTGX) | 0.9 | $9.3M | 1.1M | 8.59 | |
Synlogic | 0.7 | $6.6M | 700k | 9.38 | |
Denali Therapeutics (DNLI) | 0.6 | $6.4M | 325k | 19.69 | |
Rhythm Pharmaceuticals (RYTM) | 0.6 | $6.3M | 319k | 19.90 | |
Corvus Pharmaceuticals (CRVS) | 0.5 | $5.4M | 470k | 11.53 | |
Newlink Genetics | 0.4 | $4.1M | 560k | 7.25 | |
Kindred Biosciences | 0.2 | $2.2M | 249k | 8.65 | |
Geron Corporation (GERN) | 0.1 | $1.5M | 350k | 4.25 |